Lysando AG
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Oct 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 25, 2026The maintenance fee for Antimicrobial Agents (US 10,329,550) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.
- 1 fee due May 26, 2027The maintenance fee for Method of reducing biofilms (US 10,485,854) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
- 1 fee due Oct 16, 2027The maintenance fee for Antimicrobial proteins (US 11,958,890) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.
Recent changes
- 2 terms have ended since Aug 23, 2026
- Sep 30 US 8,846,865 Endolysin Obpgplys · lapsed on the fee record
- Aug 30 US 11,427,812 New Antimicrobial Agents Against Staphylococcus Aureus · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,906,365 | Antimicrobial Agents In force · High confidence | In force | High confidence | |
| US 10,485,854 | Method of reducing biofilms In force · USPTO record | In force | USPTO record | |
| US 9,534,223 | Method of reducing biofilms In force · USPTO record | In force | USPTO record | |
| US 10,329,550 | Antimicrobial Agents In force · High confidence | In force | High confidence | |
| US 10,184,120 | Modified KZ144 Endolysin Sequence In force · High confidence | In force | High confidence | |
| US 10,167,462 | Modified EL188 Endolysin Sequence In force · High confidence | In force | High confidence | |
| US 11,958,890 | Antimicrobial proteins In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 7: 3 patents in force now held by others · 4 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 abandoned · 8 no status recorded
Rows 11 to 11 of 11 are for members. The first 10 are on the company page.
Pro members see all 11 published applications.